At the American Society of Clinical Oncology meeting, two significant breakthroughs in cancer treatment were highlighted. First, a Canadian study demonstrated that a prescribed exercise routine could outperform chemotherapy in preventing colon cancer recurrence. Patients following the exercise regimen saw better survival rates than those receiving standard chemotherapy. Second, AstraZeneca showcased its immunotherapy drug Imfinzi, which significantly improved gastric cancer survival rates when combined with chemotherapy post-surgery. These developments underscore a shift towards integrating exercise and immunotherapy into cancer treatment protocols, potentially reducing reliance on traditional methods like chemotherapy.
— new from Business Insider
